Evidence map›Paper›PMID 22933539›Full record

ArticleThe Journal of clinical endocrinology and metabolism2012

Insulin-mediated FFA suppression is associated with triglyceridemia and insulin sensitivity independent of adiposity.

Nikki C Bush, Rita Basu, Robert A Rizza, K Sreekumaran Nair, Sundeep Khosla, Michael D Jensen

Abstract read
In one paragraph

Article in The Journal of clinical endocrinology and metabolism, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Effect of Dehydroepiandrosterone and Testosterone Supplementation on Systemic Lipolysis.The Journal of clinical endocrinology and metabolism · 2016
    Trial
  4. Trial
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Myocardial Fat Accumulation Is Independent of Measures of Insulin Sensitivity.The Journal of clinical endocrinology and metabolism · 2015
    Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Nikki C BushMayo Clinic, Endocrine Research Unit, 200 First Street SW, Room 5-194 Joseph, Rochester, Minnesota 55905, USA.
Rita Basu
Robert A Rizza
K Sreekumaran Nair
Sundeep Khosla
Michael D Jensen

Funding

ZESTRIL VS. VERAPAMIL IN THE TREATMENT OF HYPERTENSIONM01RR000585 · NCRR · MAYO CLINIC ROCHESTER · PI RIZZA, ROBERT A. · 1985 to 2006
$30.4M
Obesity and Energy Metabolism CoreP30DK050456 · NIDDK · UNIVERSITY OF MINNESOTA TWIN CITIES · PI BERNLOHR, DAVID A · 1995 to 2015
$17.0M
DIABETES AND METABOLISMT32DK007352 · NIDDK · MAYO CLINIC ROCHESTER · PI MICHAEL D. JENSEN · 1986 to 2026
$9.4M
FFA METABOLISM IN DIFFERENT TYPES OF HUMAN OBESITYR01DK040484 · NIDDK · MAYO CLINIC ROCHESTER · PI MICHAEL D. JENSEN · 1993 to 2026
$8.2M
Free Fatty Acid Metabolism in Different Types of Human ObesityR37DK040484 · NIDDK · MAYO CLINIC ROCHESTER · PI JENSEN, MICHAEL D. · 2003 to 2012
$4.1M
FFA METABOLISM IN DIFFERENT TYPES OF HUMAN OBESITYR29DK040484 · NIDDK · MAYO CLINIC COLL OF MEDICINE, ROCHESTER · PI JENSEN, MICHAEL D. · 1988 to 1992
–
NCRR NIH HHS M01 RR000585NCRR NIH HHS RR00585NIA NIH HHS P01AG14283NIDDK NIH HHS DK07352NIDDK NIH HHS DK40484NIDDK NIH HHS P30 DK050456NIDDK NIH HHS R01 DK040484NIDDK NIH HHS R37 DK040484NIDDK NIH HHS T32 DK007352
6 · The paper itself

Abstract

contextA central/visceral fat distribution and excess free fatty acid (FFA) availability are associated with dyslipidemia and insulin resistance. However, these two characteristics often coexist, making it difficult to detect the independent contributions of each. Whether FFA suppression is more closely linked to metabolic abnormalities is not clear.

objectiveThe aim of the study was to examine the relationship between FFA suppression, body fat distribution, and fitness as contributors toward insulin resistance and hypertriglyceridemia.

designWe measured systemic palmitate turnover using an iv infusion of [9,10-(3)H]palmitate; upper body sc adipose tissue (UBSQ) and visceral adipose tissue (VAT) with dual-energy x-ray absorptiometry and a single-slice abdominal computed tomography scan; fitness with a graded exercise treadmill test; and insulin sensitivity with both the iv glucose tolerance test (IVGTT) (SI(IVGTT)) and mixed meal tolerance test (SI(Meal)).

settingThe study was conducted at a General Clinical Research Center.

participantsBaseline data were obtained from 140 elderly adults (age, 60-88 yr; 83 males) and 60 young adults (age, 18-31 yr; 31 males) who participated in a previously published trial assessing the effects of 2-yr supplementation of dehydroepiandrosterone or testosterone on body composition, glucose metabolism, and bone density.

interventionsThere were no interventions.

main outcome measuresWe measured fasting plasma triglyceride (TG) concentrations, SI(IVGTT), and SI(Meal).

resultsUsing multivariate regression analysis, the strongest combined predictors of TG concentrations were VAT, postmeal nadir FFA concentrations, sex, and age. The best predictors of SI(IVGTT) were IVGTT nadir palmitate concentration, VAT, UBSQ fat, fitness, and age, whereas the best predictors of SI(Meal) were meal nadir palmitate concentration, UBSQ fat, fitness, and sex.

conclusionsFFA suppression is associated with both fasting TG concentrations and insulin sensitivity, independent of measures of adiposity.

Indexed as

Adipose TissueAdiposityAdolescentAdultAgedAged, 80 and overBody Fat DistributionFatty Acids, NonesterifiedFemaleGlucose Tolerance TestHumansHypertriglyceridemiaInsulinInsulin ResistanceMaleMiddle AgedFatty Acids, NonesterifiedInsulinTriglycerides

Identifiers

PMID22933539
PMCPMC3485612

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.